The collaboration links WeInfuse’s end-to-end infusion management software with TailorMed’s medication success platform. By integrating these systems, providers gain automated access to a network that has secured over $7.4 billion in financial assistance since 2020. This connection allows clinical staff to identify patient support opportunities without leaving their existing workflow, addressing affordability and adherence concerns at the point of care.

TailorMed CEO Srulik Dvorsky noted that the integration serves to bridge the gap between patients and critical resources, while WeInfuse CEO Bryan Johnson emphasized the move as a strategic expansion of their commitment to operational efficiency. With TailorMed’s infrastructure currently reaching 75 million patients across thousands of hospitals and clinics, the move provides a significant technical upgrade for infusion centers looking to reduce administrative friction and improve treatment initiation rates.